Healthy Subjects Clinical Trial
Official title:
Activation of A-delta-fibres and C-fibres in a First Degree Thermal Injury in Volunteers
The aim of this study is to measure reaction times and thermal detection thresholds to CO2 laser stimulation of the skin, before and after a first degree thermal injury, in the primary and secondary hyperalgesia area, in order to investigate whether different nerve-fiber classes are activated in the post-injury phase. The study results are expected to uncover existence of a peripheral inflammatory input contributing to secondary hyperalgesia.
BACKGROUND The conduction speed of peripheral nerve fibers depends on the nerve diameter.
The conduction velocity of large myelinated fibers are 50 - 120 m/s, while for the smaller
myelinated A-delta- and unmyelinated C-fibers, they are in the range of 5-10 m/s, and 0.5-1
m/s, respectively. Applying short laser pulses with a high energy density and
synchronization, simple reaction times can be used to determine the type of fiber class that
has been activated. Research from the group of Plaghki and colleagues has shown that when
stimulating surface areas are between 15 and 50 sq.mm at a supra-threshold intensity for
activating A-delta-fibers, a typical bimodal response pattern is observed with a first peak
centered around 400 ms and a second around 850 ms. Whereas the early peak is due to
activation of A-delta-fibers, the second peak is caused by C-fiber activation.
HYPOTHESIS Following a mild thermal skin injury (47ºC, 420 s, 9.0 or 12.5 sq.cm area) the
injured area is associated with erythema and an increased sensitivity, i.e. pain is easily
evoked by mechanical and thermal stimuli in the primary hyperalgesia area. In normal skin
surrounding the injury mechanical and thermal allodynia and hyperalgesia, are present.
Innocuous stimuli in this secondary hyperalgesia area may elicit pain. This is believed to
be a central process suggested by pioneering research in the 1980s and 1990s. The term for
this phenomenon is heterosynaptic central facilitation meaning that innocuous stimuli may
activate normally high-threshold nociceptive dorsal horn neurons leading to allodynia. This
conversion of an innocuous stimulus in normal skin just outside of the injury, to a pain
generating stimulus, is the result of a change in the sensory processing within the CNS.
This processing is probably regulated by spino-bulbo-spinal loops including the rostral
ventro-medial medulla (RVM) and locus coeruleus (LC).
The study hypotheses are, first, that the reaction times at the thermal injury site (i.e.
primary hyperalgesia area) are changed compared to the pre-injury level. Second, that the
sensory changes in the secondary hyperalgesia area, following a thermal injury, are not
exclusively centrally mediated, but that also changes in peripheral afferents, e.g.
A-delta-fibers (AMH type I) are demonstrable by assessments of reaction times to CO2 laser
pulses.
A well-known alternative to laser stimulation is the use of a contact thermode with a much
larger stimulation area, i.e. 2.5 to 16 sq.cm. The substantially larger area of the contact
thermode, combined with a slower heating rate, compared to the laser stimulus (< 0.5 sq.cm,
10 ms), may induce pronounced spatial and temporal summation, interfering with accurate
interpretation of sensory data. A recent method-comparison study in patients with
postherpetic neuralgia, comparing assessments obtained by a contact thermode (9 sq.cm) and
by laser stimuli (< 0.25 sq.mm), indicates that the laser method is more sensitive and
specific in detecting thermal sensory abnormalities. Since the laser stimulus gives a
steeper slope of heating profile and a more synchronized activation of warmth- and
heat-sensitive small fibers, i.e. C- and A-delta-fibers, in the skin laser stimulation is
the preferred method in the present study.
CLINICAL IMPLICATIONS The propensity for developing secondary hyperalgesia may reflect a
predisposition for developing persistent postsurgical pain. It has been estimated that 2-10%
of patients undergoing otherwise uncomplicated surgical procedures will suffer from
persistent postsurgical pain. Investigating the pathophysiological mechanisms behind
secondary hyperalgesia may therefore increase our understanding of the transition to chronic
pain and thereby improve our management strategies for this large patient group.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05483998 -
A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants
|
Phase 1 | |
Recruiting |
NCT02235012 -
Cognitive Biases Under Ketamine
|
N/A | |
Recruiting |
NCT02417714 -
Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
|
||
Completed |
NCT04418973 -
Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject.
|
N/A | |
Completed |
NCT05088343 -
Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects
|
Phase 1 | |
Not yet recruiting |
NCT06248801 -
Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets
|
Phase 1 | |
Terminated |
NCT04068259 -
Single Ascending Dose Study of PBI-4547 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03279302 -
Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects
|
Phase 1 | |
Not yet recruiting |
NCT06233162 -
Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets
|
Phase 1 | |
Recruiting |
NCT04159844 -
Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects
|
N/A | |
Completed |
NCT06137911 -
Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults.
|
Phase 1 | |
Completed |
NCT04849286 -
Measurement of HTL0016878 in Cerebrospinal Fluid
|
Phase 1 | |
Not yet recruiting |
NCT06233227 -
Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule
|
Phase 1 | |
Completed |
NCT04096157 -
A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants
|
Phase 1 | |
Completed |
NCT01200368 -
Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants
|
Phase 3 | |
Recruiting |
NCT05805033 -
Peri-Implant Soft Tissue Integration in Humans: Influence of Material
|
N/A | |
Completed |
NCT04027803 -
Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris®
|
Phase 1 | |
Recruiting |
NCT03467880 -
Multicenter Study of Impulse Oscillometry in Chinese
|
N/A | |
Completed |
NCT02903095 -
Single Ascending Dose Study of TD-1439 in Healthy Subjects
|
Phase 1 | |
Active, not recruiting |
NCT02341508 -
A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers
|
Phase 1 |